ARCHIVES

NCI To Stop All Support For WHT After March 31

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

NCI Launches Effort In Cancer Education For Older Americans; Also An ACS Goal, Dodd Tells Writers

March 29, 1991

NCI CTEP Approved Trials For the Month of March

March 29, 2013

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002